Jogeswar Mohapatra

发表

Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis

Mukul R Jain, G. Shah, A. Chatterjee, 2014, Immunopharmacology and immunotoxicology.

Involvement of adipokines in rimonabant‐mediated insulin sensitivity in ob/ob mice

Satinder K. Singh, R. Balaraman, Mukul R Jain, 2009, The Journal of pharmacy and pharmacology.

Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT-1 activation.

Mukul R Jain, Hiren M Patel, D. Pandey, 2014, Cytokine.

Retinol‐binding protein 4 : a possible role in cardiovascular complications

R. Balaraman, Mukul R Jain, Aviseka Acharya, 2011, British journal of pharmacology.

Subtherapeutic Dose of Pioglitazone Reduces Expression of Inflammatory Adipokines in db/db Mice

Satinder K. Singh, R. Balaraman, Mukul R Jain, 2009, Pharmacology.

Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice

Mukul R Jain, A. Chatterjee, Manoranjan M. Sharma, 2017, Journal of diabetes.

Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells

Ashutosh Kumar Singh, S. Bandyopadhyay, H. Kumar, 2019, Haematologica.

ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

D. Bandyopadhyay, Rajiv Sharma, N. Srinivas, 2020, Pharmacology research & perspectives.

Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?

Mukul R Jain, Aviseka Acharya, A. Chatterjee, 2013, European journal of pharmacology.

Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis.

Mukul R Jain, Hiren M Patel, D. Pandey, 2013, International immunopharmacology.